These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24307207)

  • 1. Therapeutic drug monitoring of zuclopenthixol in a double-blind placebo-controlled discontinuation study in adults with intellectual disabilities and aggressive behaviour.
    Schwarz V; Reis O; Glaser T; Thome J; Hiemke C; Haessler F
    Pharmacopsychiatry; 2014 Jan; 47(1):29-32. PubMed ID: 24307207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zuclopenthixol in adults with intellectual disabilities and aggressive behaviours: discontinuation study.
    Haessler F; Glaser T; Beneke M; Pap AF; Bodenschatz R; Reis O;
    Br J Psychiatry; 2007 May; 190():447-8. PubMed ID: 17470962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of aggressive behavior problems in boys with intellectual disabilities using zuclopenthixol.
    Hässler F; Dück A; Jung M; Reis O
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):579-81. PubMed ID: 25514543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zuclopenthixol treatment of behavioral disturbances in mentally retarded children and adolescents: an open-label study.
    Spivak B; Mozes T; Mester R; Kodelik M; Weizman A
    J Child Adolesc Psychopharmacol; 2001; 11(3):279-84. PubMed ID: 11642477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind placebo-controlled discontinuation study of zuclopenthixol for the treatment of aggressive disruptive behaviours in adults with mental retardation - secondary parameter analyses.
    Hässler F; Glaser T; Pap AF; Beneke M; Diefenbacher A; Reis O;
    Pharmacopsychiatry; 2008 Nov; 41(6):232-9. PubMed ID: 19067260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of zuclopenthixol on aggressive disruptive behavior in adults with mental retardation--a 2-year follow-up on a withdrawal study.
    Hässler F; Glaser T; Reis O
    Pharmacopsychiatry; 2011 Nov; 44(7):339-43. PubMed ID: 21993867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zuclopenthixol decanoate in the management of behavioural disorders in mentally handicapped patients.
    Izmeth MG; Khan SY; Kumarajeewa DI; Shivanathan S; Veall RM; Wiley YV
    Pharmatherapeutica; 1988; 5(4):217-27. PubMed ID: 2902642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of zuclopenthixol compared with haloperidol in the treatment of behavioural disturbances in learning disabled patients.
    Malt UF; Nystad R; Bache T; Noren O; Sjaastad M; Solberg KO; Tønseth S; Zachariassen P; Maehlum E
    Br J Psychiatry; 1995 Mar; 166(3):374-7. PubMed ID: 7788130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind comparison of zuclopenthixol tablets with placebo in the treatment of mentally handicapped in-patients with associated behavioural disorders.
    Singh I; Owino WJ
    J Intellect Disabil Res; 1992 Dec; 36 ( Pt 6)():541-9. PubMed ID: 1477491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zuclopenthixol and haloperidol/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study.
    Fuglum E; Schillinger A; Andersen JB; Belstad BE; Jensen D; Müller F; Müller KJ; Schulstad B; Elgen K
    Pharmatherapeutica; 1989; 5(5):285-91. PubMed ID: 2568639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
    Chouinard G; Safadi G; Beauclair L
    J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clopenthixol decanoate in the management of aggressive mentally handicapped patients.
    Mlele TJ; Wiley YV
    Br J Psychiatry; 1986 Sep; 149():373-6. PubMed ID: 3779305
    [No Abstract]   [Full Text] [Related]  

  • 13. Zuclopenthixol and melperon in the treatment of elderly patients: a double-blind, controlled, multi-centre study.
    Nygaard H; Bakke K; Brudvik E; Lien GK; Moe TJ; Elgen K
    Pharmatherapeutica; 1988; 5(3):152-8. PubMed ID: 2896359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zuclopenthixol, melperone and haloperidol/levomepromazine in the elderly. Meta-analysis of two double-blind trials at 15 nursing homes in Norway.
    Nygaard HA; Fuglum E; Elgen K
    Curr Med Res Opin; 1992; 12(10):615-22. PubMed ID: 1353014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eltoprazine in aggressive mentally handicapped patients: a double-blind, placebo- and baseline-controlled multi-centre study. The Eltoprazine Aggression Research Group.
    de Koning P; Mak M; de Vries MH; Allsopp LF; Stevens RB; Verbruggen R; Van den Borre R; van Peteghem P; Kohen D; Arumainayagam M
    Int Clin Psychopharmacol; 1994 Sep; 9(3):187-94. PubMed ID: 7814828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosing of neuroleptics in elderly demented patients with aggressive and agitated behaviour: a double-blind study with zuclopenthixol.
    Nygaard HA; Bakke K; Brudvik E; Elgen K; Lien GK
    Curr Med Res Opin; 1994; 13(4):222-32. PubMed ID: 7882702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pipothiazine palmitate in the management of aggressive mentally handicapped patients.
    Lynch DM; Eliatamby CL; Anderson AA
    Br J Psychiatry; 1985 May; 146():525-9. PubMed ID: 2861874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming the barriers experienced in conducting a medication trial in adults with aggressive challenging behaviour and intellectual disabilities.
    Oliver-Africano P; Dickens S; Ahmed Z; Bouras N; Cooray S; Deb S; Knapp M; Hare M; Meade M; Reece B; Bhaumik S; Harley D; Piachaud J; Regan A; Ade Thomas D; Karatela S; Rao B; Dzendrowskyj T; Lenôtre L; Watson J; Tyrer P
    J Intellect Disabil Res; 2010 Jan; 54(1):17-25. PubMed ID: 19627427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
    Hovens JE; Dries PJ; Melman CT; Wapenaar RJ; Loonen AJ
    J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using venlafaxine to treat behavioral disorders in patients with autism spectrum disorder.
    Carminati GG; Gerber F; Darbellay B; Kosel MM; Deriaz N; Chabert J; Fathi M; Bertschy G; Ferrero F; Carminati F
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():85-95. PubMed ID: 26361994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.